GlassScriptPhysician profile
Sergey V Bogdan
NPI 1700894110
$1,096.43
in general payments reported to CMS, 2019-2025
12 companies · $31.10 in 2025
The $31.10 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $157 · 2021: $185 · 2022: $191 · 2024: $16.70 · 2025: $31.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $269.60 | 2019-2020 | |
| Boston Scientific Corporation | $201.32 | 2019 | |
| Abbott Laboratories | $185.65 | 2021-2024 | Eterna |
| Nevro Corp. | $159.57 | 2019-2022 | |
| Painteq LLC | $66.99 | 2021 | |
| Stimwave Technologies Incorporated | $62.60 | 2019 | |
| Si-Bone, INC. | $46.30 | 2020-2025 | |
| Medtronic, INC. | $29.63 | 2022 | |
| Scilex Pharmaceuticals INC. | $23.34 | 2022 | |
| Grt US Holding, INC. | $21.77 | 2022 | |
| Orthogenrx INC. | $15.19 | 2019 | |
| Horizon Therapeutics Plc | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Bogdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.